These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 39212047

  • 1. Prolonged in-use physicochemical and biological stability of nivolumab and pembrolizumab diluted in saline infusion bags and in partially used medication vials.
    Arnamo AH, Pluim D, Huitema AD, Jacobs BA, Beijnen JH, Nuijen B.
    J Oncol Pharm Pract; 2024 Aug 30; ():10781552241279018. PubMed ID: 39212047
    [Abstract] [Full Text] [Related]

  • 2. Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag.
    Sundaramurthi P, Chadwick S, Narasimhan C.
    J Oncol Pharm Pract; 2020 Apr 30; 26(3):641-646. PubMed ID: 31446867
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags.
    Hui A, Yin J, Liu W, Zheng K.
    Int J Pharm Compd; 2021 Apr 30; 25(3):246-257. PubMed ID: 34125716
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the Physico-Chemical and Biological Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions.
    Park D, Kim J, Yun J, Park SJ.
    Adv Ther; 2020 Oct 30; 37(10):4308-4324. PubMed ID: 32816233
    [Abstract] [Full Text] [Related]

  • 6. Stability of nivolumab in its original vials after opening and handing in normal saline bag for intravenous infusion.
    Le Guyader G, Vieillard V, Mouraud S, Do B, Marabelle A, Paul M.
    Eur J Cancer; 2020 Aug 30; 135():192-202. PubMed ID: 32599409
    [Abstract] [Full Text] [Related]

  • 7. Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations.
    Carpanese D, Rossi V, Di Paolo V, Quintieri L, Penna A, Zuccolotto G, Sebellin J, Saran C, Pipitone F, Miolo G, De Diana E, Realdon N, Rigamonti N, Di Sarra F, Coppola M, Rosato A.
    Int J Pharm; 2024 Jan 05; 649():123643. PubMed ID: 38040395
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period.
    Kim SH, Krämer I.
    J Oncol Pharm Pract; 2017 Jan 01; ():1078155217735881. PubMed ID: 29059027
    [Abstract] [Full Text] [Related]

  • 11. Stability of Procainamide Injection in Clear Glass Vials and Polyvinyl Chloride Bags.
    Donnelly RF.
    Hosp Pharm; 2017 Nov 01; 52(10):704-708. PubMed ID: 29276243
    [Abstract] [Full Text] [Related]

  • 12. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA, Kuzmission A, Ikeda K, Yasuo S.
    Clin Ther; 2008 Nov 01; 30(11):2075-87. PubMed ID: 19108795
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In-Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period.
    Tak M, Jeong H, Yun J, Kim J, Kim S, Lee Y, Park SJ.
    Drugs R D; 2023 Dec 01; 23(4):363-375. PubMed ID: 37606749
    [Abstract] [Full Text] [Related]

  • 15. Physicochemical and biological stability of diluted vedolizumab in intravenous infusion bags.
    Hendrickx TCJ, Balcaen KDH, Baert M, Haustraete J, Lambrecht BN.
    Eur J Hosp Pharm; 2024 Jan 18. PubMed ID: 38212080
    [Abstract] [Full Text] [Related]

  • 16. Stability of daptomycin reconstituted vials and infusion solutions.
    Sánchez-Rubio Ferrández J, Vázquez Sánchez R, Córdoba Díaz D, Córdoba Díaz M, Lozano Estevan MC, Molina García T.
    Eur J Hosp Pharm; 2018 Mar 18; 25(2):107-110. PubMed ID: 31156998
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The physical and chemical stability of cisplatin (Teva) in concentrate and diluted in sodium chloride 0.9%.
    Karbownik A, Szałek E, Urjasz H, Głęboka A, Mierzwa E, Grześkowiak E.
    Contemp Oncol (Pozn); 2012 Mar 18; 16(5):435-9. PubMed ID: 23788924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.